Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Renren Yang, Jia Tang, Ming Kuang & Hongying Liu. (2023) Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study. Annals of Medicine 55:1, pages 276-284.
Read now
Read now
Articles from other publishers (4)
Tianna Zhou, Yunfeng Wang, Haibo Zhang, Chaoqun Wu, Na Tian, Jianlan Cui, Xueke Bai, Yang Yang, Xiaoyan Zhang, Yuan Lu, Erica S Spatz, Joseph S Ross, Harlan M Krumholz, Jiapeng Lu, Xi Li & Shengshou Hu. (2023) Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study. The Lancet Global Health 11:1, pages e83-e94.
Crossref
Crossref
Siying Li, Xiaoyan Liang & Tianyu Yao. (2022) Association Between Dietary Patterns and the Risk of Hypertension Among General Population in China and America. Highlights in Science, Engineering and Technology 2, pages 72-81.
Crossref
Crossref
Jianqiao Chen, Jin Zheng, Zifan Zhu, Benchuan Hao, Miao Wang, Huiying Li, Yulun Cai, Shiqi Wang, Jun Li & Hongbin Liu. (2022) Impact of the CYP2D6 Genotype on Metoprolol Tolerance and Adverse Events in Elderly Chinese Patients With Cardiovascular Diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Yi Liu, Xiaomu Kong, Yongwei Jiang, Meimei Zhao, Peng Gao, Xiao Cong, Yongtong Cao & Liang Ma. (2022) Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan. International Journal of Hypertension 2022, pages 1-7.
Crossref
Crossref